These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Methotrexate chronotherapy is effective against rheumatoid arthritis. To H; Yoshimatsu H; Tomonari M; Ida H; Tsurumoto T; Tsuji Y; Sonemoto E; Shimasaki N; Koyanagi S; Sasaki H; Ieiri I; Higuchi S; Kawakami A; Ueki Y; Eguchi K Chronobiol Int; 2011 Apr; 28(3):267-74. PubMed ID: 21452922 [TBL] [Abstract][Full Text] [Related]
23. Nicorandil and theophylline can protect experimental rats against complete Freund's adjuvant-induced rheumatoid arthritis through modulation of JAK/STAT/RANKL signaling pathway. Gaafar AGA; Messiha BAS; Abdelkafy AML Eur J Pharmacol; 2018 Mar; 822():177-185. PubMed ID: 29337196 [TBL] [Abstract][Full Text] [Related]
24. The anti-arthritic effects of synthetic melittin on the complete Freund's adjuvant-induced rheumatoid arthritis model in rats. Li J; Ke T; He C; Cao W; Wei M; Zhang L; Zhang JX; Wang W; Ma J; Wang ZR; Shao ZJ Am J Chin Med; 2010; 38(6):1039-49. PubMed ID: 21061459 [TBL] [Abstract][Full Text] [Related]
25. Anti-arthritic property of crude extracts of Piptadeniastrum africanum (Mimosaceae) in complete Freund's adjuvant-induced arthritis in rats. Mbiantcha M; Almas J; Shabana SU; Nida D; Aisha F BMC Complement Altern Med; 2017 Feb; 17(1):111. PubMed ID: 28202019 [TBL] [Abstract][Full Text] [Related]
26. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand. Saito K; Mori S; Date F; Ono M Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790 [TBL] [Abstract][Full Text] [Related]
27. Clinical efficacy of buprenorphine to minimize distress in MRL/lpr mice. Swenson J; Olgun S; Radjavi A; Kaur T; Reilly CM Eur J Pharmacol; 2007 Jul; 567(1-2):67-76. PubMed ID: 17490635 [TBL] [Abstract][Full Text] [Related]
28. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736 [TBL] [Abstract][Full Text] [Related]
29. Increased expression of soluble form of vascular cell adhesion molecule-1 aggravates autoimmune arthritis in MRL-Fas(lpr) mice. Oishi H; Mizuki S; Terada M; Kudo M; Araki K; Araki M; Nose M; Takahashi S Pathol Int; 2007 Nov; 57(11):734-40. PubMed ID: 17922685 [TBL] [Abstract][Full Text] [Related]
30. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157 [TBL] [Abstract][Full Text] [Related]
31. Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp-lpr/lpr mice. Mizuochi T; Hamako J; Nose M; Titani K J Immunol; 1990 Sep; 145(6):1794-8. PubMed ID: 2391420 [TBL] [Abstract][Full Text] [Related]
32. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. Gong JH; Ratkay LG; Waterfield JD; Clark-Lewis I J Exp Med; 1997 Jul; 186(1):131-7. PubMed ID: 9207007 [TBL] [Abstract][Full Text] [Related]
33. Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis. Bond A; Cooke A; Hay FC Eur J Immunol; 1990 Oct; 20(10):2229-33. PubMed ID: 2242757 [TBL] [Abstract][Full Text] [Related]
34. [Effect of CD40 siRNA on inflammatory response of MRL/Lpr mice]. Wang ZH; Zhang W; Zhang YQ; Pang CY; Wang YF Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):771-776. PubMed ID: 27752154 [TBL] [Abstract][Full Text] [Related]
36. High expression of interleukin-1beta in the corneal epithelium of MRL/lpr mice is under the control of their genetic background. Okamoto M; Takagi M; Kutsuna M; Hara Y; Nishihara M; Zhang MC; Matsuda T; Sakanaka M; Okamoto S; Nose M; Ohashi Y Clin Exp Immunol; 2004 May; 136(2):239-44. PubMed ID: 15086386 [TBL] [Abstract][Full Text] [Related]
37. Arthritis in MRL/LPR mice and in collagen II sensitized DBA-1 mice and their use in pharmacology. Rordorf C; Pataki A; Nogues V; Schlager F; Feige U; Glatt M Int J Tissue React; 1987; 9(4):341-7. PubMed ID: 3623829 [TBL] [Abstract][Full Text] [Related]
38. Immunogenic properties of synthetic fragments of Sm-D protein in normal and lupus mice. Winska-Wiloch H; Muller S; Katz DR; Wilkinson L; Hutchings PR; Isenberg DA Lupus; 1997; 6(8):656-67. PubMed ID: 9364425 [TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive activity of 15-deoxyspergualin (15-DOS) on various models of rheumatoid arthritis. Schorlemmer HU; Bartlett RR; Schleyerbach R; Seiler FR Drugs Exp Clin Res; 1991; 17(10-11):471-84. PubMed ID: 1841036 [TBL] [Abstract][Full Text] [Related]
40. Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice. Weinberg JB Environ Health Perspect; 1998 Oct; 106 Suppl 5(Suppl 5):1131-7. PubMed ID: 9788887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]